Medical Information
Saudi Arabia
 

This medical Information website is intended only for Healthcare Professionals in the Kingdom of Saudi Arabia. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

This content is intended for Healthcare professionals in Saudi Arabia. Would you like to proceed?

I am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
SelectI am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
I am not a healthcare professionalNo, go back to the patient portal
SelectI am not a healthcare professionalNo, go back to the patient portal
Non-Saudi Arabia residents click here.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Poster
Zadik Z, Cara J, Carlsson M, Wajnrajch M, Wang R, Rosenfeld RG June 11, 2022 ENDO 2022 Growth Hormone Deficiency

Growth outcomes from the phase 2 and phase 3 studies of once weekly somatrogon vs daily genotropin in pediatric patients with growth hormone deficiency: comparisons with published literature and an international growth study database

View Presentation
Poster
Loftus J, Wogen J, Oliveri D, Benjumea D, Jhingran P, Chen Y, Alvir J, Rivero Sanz E, Kowalik J June 11, 2022 ENDO 2022 Growth Hormone Deficiency

Persistence with daily growth hormone treatment among pediatric patients with growth hormone deficiency in the UK

View Presentation
Poster
Geffner M, Ibáñez L, Maniatis A, La Torre D, Huang C, Darendelieler F, Dattani M, Maghnie M, Phillip M, Dahlgren J, Horikawa R, Gomez R, Kelly S, Wajnrajch MP June 11, 2022 ENDO 2022 Growth Hormone Deficiency

Pfizer Registry of Outcomes in Growth hormone RESearch (PROGRES): A multi-country, non-interventional prospective cohort study of patients receiving human growth hormone treatments under routine clinical care

View Presentation
Poster
Gomez R, Loftus J, Yaworsky A, Lamoureux R, Polak M, Maghnie M, Miller B June 11, 2022 ENDO 2022 Growth Hormone Deficiency

Survey of physician experience with once weekly somatrogon vs once daily somatropin regimen for the treatment of pediatric patients with growth hormone deficiency: results from a cross sectional, observational study

View Presentation
Oral Presentation
Phillip M, Deal C, Silverman L, Henocque R, Nijher M, Wajnrajch M, Wang R, Cara J September 16, 2022 ESPE 2022 Growth Hormone Deficiency

Post-hoc subgroup analysis of the pivotal phase 3 study of once-weekly somatrogon vs once-daily Genotropin: results from subjects with peak stimulated growth hormone value <6.7 ng/ml

View Presentation
Poster
Loftus J, Wogen J, Benjumea D, Jhingran P, Chen Y, Alvir J, Wajnrajch M September 17, 2022 ESPE 2022 Growth Hormone Deficiency

A real-world study of persistence with daily growth hormone therapy among children with growth hormone deficiency in Japan

View Presentation
Poster
Deal C, Silverman L, Korth-Bradley J, Roland C, Taylor C, Cara J, Wajnrajch M September 17, 2022 ESPE 2022 Growth Hormone Deficiency

Efficacy and safety of once-weekly somatrogon in pediatric subjects with growth hormone deficiency: lack of impact of anti-drug antibodies

View Presentation
Poster
Gomez R, Khadilkar V, Shembalkar J, Chu D, Ko CW, Wajnrajch M, Wang R September 17, 2022 ESPE 2022 Growth Hormone Deficiency

Post-hoc subgroup analysis of Asian subjects from the pivotal phase 3 study of once-weekly somatrogon vs once-daily Genotropin

View Presentation